Latest news
Capricor (CAPR) Securities Investigation Notice - Levi & Korsinsky - MorningstarMorningstar · Wed, 05 Aug 2026 19:09:00 GMTCAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - TradingViewTradingView · Tue, 04 Aug 2026 10:36:00 GMTFDA Panel Votes Against Deramiocel for DMD Cardiomyopathy - Endocrinology AdvisorEndocrinology Advisor · Mon, 03 Aug 2026 04:00:00 GMTCapricor Therapeutics Faces Class Action Investigation After FDA Data Concerns Trigger 64% Stock Collapse - Azat TVAzat TV · Sun, 02 Aug 2026 17:15:00 GMTCAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - TradingViewTradingView · Fri, 31 Jul 2026 17:42:39 GMTCAPR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Capricor (CAPR) - Business WireBusiness Wire · Fri, 31 Jul 2026 07:00:00 GMTFDA advisory panel votes against Capricor's Duchenne cell therapy deramiocel - DealroomDealroom · Thu, 30 Jul 2026 22:39:44 GMTCAPR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Capricor - TradingViewTradingView · Thu, 30 Jul 2026 14:24:00 GMT